在基因向平台中驱动的生物信息学为黄金提供了抗癌战略
Can Jiang1, Haixuan Wen1, Jiabin Chen1
1Department of Pathology, Xiangya Hospital, Xiangya School of Basic Medical Sciences, Central South University, Changsha, China.
Materials today. Bio
|November 10, 2025
概括
研究人员确定SDC1是三阴性乳腺癌 (TNBC) 的关键基因,将其高表达与生存率差和耐药性联系起来. 一个针对SDC1的新型金纳米集群系统有效地抑制了TNBC的进展和血管生成.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 纳米技术 纳米技术
背景情况:
- 三阴性乳腺癌 (TNBC) 具有极限的向疗法,具有高度的攻击性.
- 目前的TNBC治疗严重依赖于化疗,这凸显了对新型治疗策略的需求.
- 确定特定的分子点和有效的传递系统对于推进TNBC治疗至关重要.
研究的目的:
- 在TNBC中确定新的治疗点.
- 开发一种有效的核酸输送系统,用于TNBC治疗.
- 阐明SDC1在TNBC进展和耐药性的作用.
主要方法:
- 基因芯片数据查,以确定TNBC中差异表达的基因.
- 单细胞RNA测序 (scRNA-seq) 用于分析瘤微环境 (TME) 中的SDC1-依赖性变化.
- 构建一个in situ自反应黄金纳米集群 SDC1 shRNA向核酸输送系统.
主要成果:
- SDC1被确定为TNBC中高度表达的基因,与较差的整体存活率相关.
- 增加的SDC1表达与TNBC中埃托化物耐药性有关.
- 开发的金纳米集群系统通过准SDC1.1,有效地抑制了TNBC血管生成.
- 发现SDC1通过调节TNBC微环境来促进瘤的进展.
结论:
- SDC1是TNBC的潜在治疗标,涉及瘤进展和耐药性.
- 一个由生物信息学驱动的平台可以促进基于纳米集群的抗癌策略的合理设计.
- 向的核酸输送系统,如开发的金纳米集群,显示出抑制TNBC生长和血管生成的希望.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.6K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.1K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
